These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8438535)

  • 1. [Legal medicine aspects of current abuse potential].
    Kauert G; Eisenmenger W
    Versicherungsmedizin; 1993 Feb; 45(1):15-7. PubMed ID: 8438535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendations.
    Br J Addict; 1991 Dec; 86(12):1527-8. PubMed ID: 1786481
    [No Abstract]   [Full Text] [Related]  

  • 3. Human drug abuse liability: testing times ahead.
    Camí J
    Br J Addict; 1991 Dec; 86(12):1525-6. PubMed ID: 1786479
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives and future on testing for abuse liability in humans.
    Camí J
    Br J Addict; 1991 Dec; 86(12):1529-31. PubMed ID: 1786482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is drug prohibition an effective tool? An analysis from the forensic viewpoint].
    Stratenwerth G
    Psychiatr Prax; 1994 Jan; 21(1):3-6. PubMed ID: 8146243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Legal and illegal drugs--status, selected problems, trends].
    Katzung W
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):689-99. PubMed ID: 1529620
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drug abuse does not discriminate.
    Lovedale L
    Colo Nurse; 2014 May; 114(2):7. PubMed ID: 25118430
    [No Abstract]   [Full Text] [Related]  

  • 8. Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.
    Woods JH
    Drug Alcohol Depend; 1990 Apr; 25(2):229-33. PubMed ID: 1970287
    [No Abstract]   [Full Text] [Related]  

  • 9. [Organizational, legal, and methodical aspects of drug abuse prevention].
    Novikov VA; Dorovskikh IV; Mal'tsev GIu; Likhachev AA; Kozlov AA
    Voen Med Zh; 2007 Apr; 328(4):62-7. PubMed ID: 17580495
    [No Abstract]   [Full Text] [Related]  

  • 10. Volatile substance abuse in the United Kingdom.
    Ramsey J; Taylor J; Anderson HR; Flanagan RJ
    NIDA Res Monogr; 1995; 148():205-49. PubMed ID: 8929892
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription Drug Abuse Task Force recommendations.
    Prescription Drug Abuse Task Force
    J Ky Med Assoc; 2003 Nov; 101(11):495-7. PubMed ID: 14635577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Forms of drug crimes. A criminologic contribution on the manifestations of the criminal production and distribution of drugs as well as their practical significance].
    Wagner G
    Arch Kriminol; 1984; 174(5-6):9-140. PubMed ID: 6525018
    [No Abstract]   [Full Text] [Related]  

  • 13. A caveat: drug policy as factor of trends in trade and use of different substances.
    Arnao G
    Int J Addict; 1990 Dec; 25(12):1485-8. PubMed ID: 2094686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abuse-related adverse drug reactions and abuse deterrent formulations].
    Papaseit E; Pérez-Mañá C; Torrens M; Farré M
    Med Clin (Barc); 2013 Nov; 141(10):454-8. PubMed ID: 24144061
    [No Abstract]   [Full Text] [Related]  

  • 15. Dealing with substance abuse in the workplace.
    Malatestinic WN; Jorgenson JA
    Hosp Pharm; 1991 Feb; 26(2):102-5. PubMed ID: 10170679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [German drug policy also successful in European comparison].
    Kinderkrankenschwester; 2003 Jan; 22(1):6-7. PubMed ID: 15984429
    [No Abstract]   [Full Text] [Related]  

  • 17. Social policy issues in narcotics abuse.
    Schmolling P
    J Health Soc Policy; 1993; 5(2):49-65. PubMed ID: 10171762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public policy statement on national drug policy. American Society of Addiction Medicine.
    J Addict Dis; 1994; 13(4):231-4. PubMed ID: 7734471
    [No Abstract]   [Full Text] [Related]  

  • 19. The necessity and utility of abuse liability evaluations in human subjects.
    Vocci FJ
    Br J Addict; 1991 Dec; 86(12):1537-42. PubMed ID: 1786484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The medicolegal aspects of the prevention and diagnosis of drug addiction].
    Kolkutin VV; Pigolkin IuI; Sosedko IuI
    Voen Med Zh; 1999 Apr; 320(4):22-5, 110. PubMed ID: 10382352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.